Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer Survival and Response to Treatment


AYDINER A., Sen F., Tambas M., Ciftci R., Eralp Y., Saip P., ...Daha Fazla

MEDICINE, cilt.94, sa.52, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 94 Sayı: 52
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1097/md.0000000000002341
  • Dergi Adı: MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Metaplastic breast carcinoma (MBC) differs from classic invasive ductal carcinomas regarding incidence, pathogenesis, and prognosis. The purpose of this study was to compare patients with MBC with clinicopathologic and treatment-matched patients with triple-negative breast carcinoma (TNBC) in terms of response to treatment, progression, and survival.